Jefferies Downgrades Allergan (AGN) to Hold

May 2, 2008 9:48 AM EDT

Jefferies downgrades Allergan (NYSE: AGN) from Buy to Hold with a $62 price target.

Allergan, Inc., a multi-specialty healthcare company, discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide.


Related Categories

Downgrades

Stocks Mentioned

AGN 26.22

-21.23 -44.74%
Volume: 439,415
Track AGN


Related Entities


Add Your Comment